Uncategorized
-
Court Upholds FTC Decision to Block IQVIA-DeepIntent Merger, Safeguarding Competition in Pharma Programmatic Advertising
In a significant development for the pharmaceutical industry, a U.S. court affirmed the Federal Trade Commission’s decision to halt the…
Read More » -
Pfizer Closes $43 Billion Seagen Deal, Overhauls Commercial Structure Amid Regulatory Clearance
Pfizer, the New York-based pharmaceutical giant, is set to complete its $43 billion acquisition of cancer drugmaker Seagen this Thursday,…
Read More » -
2024 Outlook: Leveraging Emerging Digital Health Trends in Pharmaceutical Marketing
Rock Health recently posted an excellent summary of the key digital trends they are seeing heading into 2024. Using the…
Read More » -
Pfizer discontinues twice daily weight loss pill due to high rates of adverse side effects
Pfizer announced on Friday that it would stop developing the twice-daily version of its experimental weight loss pill. While most common adverse events…
Read More » -
Weight Loss Study: Semaglutide vs. Tirzepatide
As we head out of Thanksgiving feasting and into the end of year holiday celebrations, many Americans may take comfort…
Read More »